is phentermine a glp 1 receptor agonist GLP-1 agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Anti-Obesity medications (Mechanism of Action)

Cyclic peptide-based nanostructures as efficient siRNA carriers

While research is still ongoing, there is some evidence to suggest that BPC-157 may have neuroprotective effects and could potentially be used in the treatment of traumatic brain injury

To enhance the therapeutic efficacy of resveratrol, we investigated the protective effects of liposomal resveratrol (LR) in a streptozotocin-induced diabetic rat model at doses of 20 and 40 mg/kg

Known as the "master antioxidant," glutathione is essential for protecting cells from oxidative stress and damage c

L-carnitine may also benefit those with existing cardiovascular problems, suggests a study published in the Journal of the American College of Cardiology